Therapy News and Research

RSS

Women with a condition called vulvodynia process pain differently

The researchers tested 17 women with vulvodynia and 23 similar women without pain at 23 sites throughout the vulva and at the deltoid muscle, the shin and the thumbnail to assess pain tolerance. They found the women with vulvodynia had lower tolerance at all sites than the women without vulvodynia.

13 Jul 2004

Updated guidelines for treatment of blood cholesterol

The National Cholesterol Education Program (NCEP) has updated its guidelines for treatment of blood cholesterol, suggesting that people at risk for heart attack and stroke would benefit from more intensive cholesterol-lowering therapies.

13 Jul 2004

Adults with asthma may have an increased risk of developing chronic obstructive pulmonary disease

According to a 20-year study published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), patients with asthma were 12 times more likely than nonasthmatics to develop COPD later in life.

13 Jul 2004

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

A West African community has joined the network of community-based treatment support programs that form Bristol-Myers Squibb's real world field test of how HIV/AIDS treatment can best be combined with community-based care in some of the poorest and most remote areas of sub-Saharan Africa.

13 Jul 2004

Latanoprost is safe as adjunctive therapy for long-term treatment of common form of glaucoma

Glaucoma is a condition in which the pressure inside the eyes rises. If untreated, glaucoma may damage the optic nerve and other parts of the eye, and my lead to blindness. According to information in the article, latanoprost is a derivative of the chemical prostaglandin F2-alpha. Prostaglandin derivatives have been shown to help lower intraocular pressure (IOP).

13 Jul 2004

Findings alleviate concerns of physicians reluctant to prescribe beta-blockers because of cardiovascular adverse effects

Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Jul 2004

Fluoxetine, orlistat, and sibutramine can diabetics achieve significant weight loss

According to information in the article, the prevalence of obesity in the United States increased from 12 percent in 1991 to 18 percent in 1998. Recent survey data indicate that 65 percent of Americans are overweight.

13 Jul 2004

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).

12 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

GSK and Boehringer Ingelheim to develop treatment for HIV infection specifically for the developing world

GlaxoSmithKline and Boehringer Ingelheim announced today that the companies have signed a letter of intent for an accelerated development programme for a co-package for Combivir® (lamivudine/zidovudine) and Viramune® (nevirapine) for chronic treatment of HIV infection in the developing world.

12 Jul 2004

Educating patients can help limit side effects of chemotherapy and radiation

A new study finds patients about to undergo chemotherapy or radiation expect a high number of side effects, and that age, gender, educational background, and the type of cancer all influence how many side effects a patient expects.

12 Jul 2004

HIV patients treated with antiretroviral therapy early after infection do test negative

UCSF researchers have found that some HIV patients treated with antiretroviral therapy early after infection do test negative, at some point, for the virus. Study findings showed this result in six of 87 patients.

12 Jul 2004

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Increasing the body's production of growth hormone may be an effective treatment for HIV lipodystrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.

11 Jul 2004

Average cost for providing primary care to an HIV-infected patient is $30 USD per visit

Researchers at Johns Hopkins and University of Witwatersrand, South Africa, have determined that the actual average cost for providing primary care to an HIV-infected patient is $30 USD per visit.

11 Jul 2004

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Results from a three year double-blinded trial which compared antiretroviral therapies show that the combination regimens of tenofovir DF and stavudine, are equally effective, though tenofovir DF has more favorable outcomes with respect to cholesterol levels and the nervous system.

11 Jul 2004

Nevirapine effective in reducing the risk of transmission of HIV at birth

A drug called nevirapine has been shown to be effective in reducing the risk of transmission of HIV at birth, but combination therapy of nevirapine and zidovudine does not improve outcomes, according to a study published in the current HIV/AIDS Journal of the American Medical Association.

11 Jul 2004

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Aids is one of the principal causes of infant mortality in many developing countries. Viral transmission takes place during pregnancy (in utero), at the moment of childbirth or even during breastfeeding.

10 Jul 2004

Human ability to generate feelings through imagery could be the key to a breakthrough in the treatment of mental health problems

A leading psychologist has claimed that humans’ ability to generate feelings through imagery – as, for instance, becoming sexually aroused through fantasy - could be the key to a breakthrough in the treatment of a range of mental health problems.

10 Jul 2004

Cheap and cheerful treatment for people who deliberately harm themselves more effective than long-term expensive therapies

A ‘cheap and cheerful’ treatment for people who deliberately harm themselves has been shown to be more effective than long-term, far more expensive therapies – as long as the therapists are good at their job.

10 Jul 2004

Children with chronic fatigue syndrome who exercise recover faster than children who are encouraged to give way to their symptoms

Children with chronic fatigue syndrome (CFS) who leave their beds, start to exercise and are supported by parents who acknowledge the psychological dimension of this debilitating condition, recover faster than children who are encouraged to give way to their symptoms.

10 Jul 2004

Therapy News and Research

Women with a condition called vulvodynia process pain differently

Updated guidelines for treatment of blood cholesterol

Adults with asthma may have an increased risk of developing chronic obstructive pulmonary disease

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

Latanoprost is safe as adjunctive therapy for long-term treatment of common form of glaucoma

Findings alleviate concerns of physicians reluctant to prescribe beta-blockers because of cardiovascular adverse effects

Fluoxetine, orlistat, and sibutramine can diabetics achieve significant weight loss

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

GSK and Boehringer Ingelheim to develop treatment for HIV infection specifically for the developing world

Educating patients can help limit side effects of chemotherapy and radiation

HIV patients treated with antiretroviral therapy early after infection do test negative

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Average cost for providing primary care to an HIV-infected patient is $30 USD per visit

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Nevirapine effective in reducing the risk of transmission of HIV at birth

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Human ability to generate feelings through imagery could be the key to a breakthrough in the treatment of mental health problems

Cheap and cheerful treatment for people who deliberately harm themselves more effective than long-term expensive therapies

Children with chronic fatigue syndrome who exercise recover faster than children who are encouraged to give way to their symptoms

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News